Skip to content
healthcare.dev

Buscapina

NDC 69729-131, Acetaminophen, Caffeine, Pyrilamine Maleate, tablet, coated, from OPMX LLC.

Product NDC
69729-131
Status
Listed
Labeler
OPMX LLC
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69729-131 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN500 mg/1
  • CAFFEINE60 mg/1
  • PYRILAMINE MALEATE15 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Methylxanthine [EPC]; Xanthines [CS]

Package NDCNDC-11Package
69729-131-506972901315050 POUCH in 1 CARTON (69729-131-50) / 2 TABLET, COATED in 1 POUCH
69729-131-726972901317272 PACKET in 1 CARTON (69729-131-72) / 2 TABLET, COATED in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69729-131 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69729-131 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69729-131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.